About Epiloid Biotechnology
Epiloid Biotechnology is a company based in Toronto (Canada) founded in 2022 by Mark Aquilino, Rohit Singla, and Peter Carlen. Epiloid Biotechnology offers products and services including Organoids Service and Predictions Service. Epiloid Biotechnology operates in a competitive market with competitors including bit.bio, Herophilus, Norganoid, Neurxstem and Cognistem Biosciences, among others.
- Headquarter Toronto, Canada
- Founders Mark Aquilino, Rohit Singla, Peter Carlen
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epiloid Biotechnology
Epiloid Biotechnology offers a comprehensive portfolio of products and services, including Organoids Service and Predictions Service.
Service for growing and analyzing human brain organoids for research.
Tool for predicting preclinical drug efficacy in neurology.
Funding Insights of Epiloid Biotechnology
Detailed funding history for Epiloid Biotechnology
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Epiloid Biotechnology
Investment portfolio details for Epiloid Biotechnology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Epiloid Biotechnology
Detailed financials for Epiloid Biotechnology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Epiloid Biotechnology Comparisons
Peer comparison for Epiloid Biotechnology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Epiloid Biotechnology
Epiloid Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as bit.bio, Herophilus, Norganoid, Neurxstem and Cognistem Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a platform for synthetic and stem cell therapies
|
|
| Locked | Locked | Locked |
Developer of drug discovery platform to treat neurological disorders
|
|
| Locked | Locked | Locked |
Brain-on-chip solutions are developed to accelerate drug research.
|
|
| Locked | Locked | Locked |
Neural organoid platform is developed from iPSC for brain research.
|
|
| Locked | Locked | Locked |
Develops iPS-derived neuronal models for Alzheimer's disease studies.
|
Detailed competitors of Epiloid Biotechnology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Epiloid Biotechnology
Complete news archive for Epiloid Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epiloid Biotechnology
Epiloid Biotechnology was founded in 2022.
Epiloid Biotechnology is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Epiloid Biotechnology was founded in 2022 in Toronto, Canada, within the biotechnology sector. 3D human cerebral organoid assays are offered for testing neurological drugs. A platform is utilized to evaluate drug efficacy through assessment and recording of cerebral responses to induced diseases, including Epilepsy and Parkinsons. Insights into potential patient responses during clinical trials are thereby generated.
Epiloid Biotechnology's top competitors include bit.bio, Herophilus and Neurxstem.
Epiloid Biotechnology offers Organoids Service and Predictions Service.